Stem Cell Law, Hope, and Barriers

This episode explores the complicated landscape of stem cell therapy regulation in the United States, focusing on the FDA's restrictive definitions and their impact on doctors and patients. Dr. Rick Jacoby and his guest discuss the legal hurdles that drive Americans to seek treatment abroad, the role of big pharma, and the challenges of pursuing innovation. The conversation highlights the tension between scientific potential and regulatory roadblocks, leaving many to question the future of regenerative medicine in America.